Normorphine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Normorphine
Normorphine.svg
Systematic (IUPAC) name
3,6α-Dihydroxy-4,5α-epoxy-7,8-didehydromorphinan
Clinical data
Legal status
Identifiers
CAS Number 466-97-7 YesY
ATC code none
PubChem CID: 5462508
IUPHAR/BPS 1630
ChemSpider 4575435 N
UNII XUI1Y24IMI
Synonyms Normorphine
Chemical data
Formula C16H17NO3
Molecular mass 271.311 g/mol
  • c1cc(c2c3c1C[C@@H]4[C@H]5[C@]3(CCN4)[C@@H](O2)[C@H](C=C5)O)O
  • InChI=1S/C16H17NO3/c18-11-3-1-8-7-10-9-2-4-12(19)15-16(9,5-6-17-10)13(8)14(11)20-15/h1-4,9-10,12,15,17-19H,5-7H2/t9-,10+,12-,15-,16-/m0/s1 N
  • Key:ONBWJWYUHXVEJS-ZTYRTETDSA-N N
 NYesY (what is this?)  (verify)

Normorphine is an opiate analogue, the N-demethylated derivative of morphine, that was first described in the 1950s[1] when a large group of N-substituted morphine analogues were characterized for activity.

Normorphine has relatively little opioid activity in its own right,[2][3] but is a useful intermediate which can be used to produce both opioid antagonists such as nalorphine, and also potent opioid agonists such as N-phenethylnormorphine.[4] It is also produced as a major metabolite of morphine,[5] with its formation from morphine catalysed by the liver enzymes CYP3A4 and CYP2C8.[6]

Normorphine is a controlled substance listed under the Single Convention On Narcotic Drugs 1961 and the laws in various states implementing it; for example, in the United States it is a Schedule I Narcotic controlled substance, with an ACSCN of 9313 and an annual aggregate manufacturing quota of 18 grammes in 2013, unchanged from the prior year.

References

  1. Journal of the American Chemistry Society 75,4963 (1953)
  2. Fraser HF, Wikler A, Van Horn GD, Eisenman AJ, Isbell H. Human pharmacology and addiction liability of normorphine. Journal of Pharmacology and Experimental Therapeutics. 1958 Mar;122(3):359-69. PMID 13539761
  3. Lasagna L, De Kornfeld TJ. Analgesic potency of normorphine in patients with postoperative pain. Journal of Pharmacology and Experimental Therapeutics. 1958 Nov;124(3):260-3. PMID 13588540
  4. Daniel Lednicer. Central Analgetics. (1982), p146. ISBN 0-471-08314-3
  5. Yeh SY. Urinary excretion of morphine and its metabolites in morphine-dependent subjects. Journal of Pharmacology and Experimental Therapeutics. 1975 Jan;192(1):201-10. PMID 235634
  6. Projean D, Morin PE, Tu TM, Ducharme J. Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes. Xenobiotica. 2003 Aug;33(8):841-54. PMID 12936704